NCT02816008

Brief Summary

Cognitive rehabilitation is defined as a systematic functionally oriented intervention of therapeutic cognitive activities based on the assessment and understanding of patient's brain behavior deficits. This project focuses on restoring cognitive functions in order to understand the underlying deficits in the patient's brain by developing integrated cognitive rehabilitation scenarios in virtual reality that combine memory, attention and problem solving training with context specific motor movements.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
59

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2016

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 21, 2016

Completed
7 days until next milestone

First Posted

Study publicly available on registry

June 28, 2016

Completed
3 days until next milestone

Study Start

First participant enrolled

July 1, 2016

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2018

Completed
Last Updated

May 23, 2018

Status Verified

May 1, 2018

Enrollment Period

1.6 years

First QC Date

June 21, 2016

Last Update Submit

May 22, 2018

Conditions

Keywords

cognitive rehabilitationmemoryattentionspatial neglectexecutive dysfunctioning

Outcome Measures

Primary Outcomes (10)

  • Change in Digit Span Forward WAIS-IV from baseline to end of treatment and to follow-up

    Measurement of attention

    Measured at baseline, at 6 weeks (end of treatment), and at 3-months (follow-up)

  • Change in Corsi block tapping test from baseline to end of treatment and to follow-up

    Measurement of attention

    Measured at baseline, at 6 weeks (end of treatment), and at 3-months (follow-up)

  • Change in Trail Making Test, Part A from baseline to end of treatment and to follow-up

    Measurement of attention

    Measured at baseline, at 6 weeks (end of treatment), and at 3-months (follow-up)

  • Change in Rey Auditory Verbal Learning Test from baseline to end of treatment and to follow-up

    Measurement of episodic memory

    Measured at baseline, at 6 weeks (end of treatment), and at 3-months (follow-up)

  • Change in Digit Span Backward WAIS-IV from baseline to end of treatment and to follow-up

    Measurement of working memory

    Measured at baseline, at 6 weeks (end of treatment), and at 3-months (follow-up)

  • Change in Corsi block-tapping test reversed from baseline to end of treatment and to follow-up

    Measurement of working memory

    Measured at baseline, at 6 weeks (end of treatment), and at 3-months (follow-up)

  • Change in Frontal Assessment Battery from baseline to end of treatment and to follow-up

    Measurement of executive functioning

    Measured at baseline, at 6 weeks (end of treatment), and at 3-months (follow-up)

  • Change in Trail Making Test, Part B from baseline to end of treatment and to follow-up

    Measurement of set-shifting

    Measured at baseline, at 6 weeks (end of treatment), and at 3-months (follow-up)

  • Change in Digit Symbol Coding in WAIS-IV from baseline to end of treatment and to follow-up

    Measurement of processing speed

    Measured at baseline, at 6 weeks (end of treatment), and at 3-months (follow-up)

  • Change in Star Cancellation test from baseline to end of treatment and to follow-up

    Measurement of spatial neglect

    Measured at baseline, at 6 weeks (end of treatment), and at 3-months (follow-up)

Secondary Outcomes (4)

  • Change in Montreal Cognitive Assessment from baseline to end of treatment and to follow-up

    Measured at baseline, at 6 weeks (end of treatment), and at 3-months (follow-up)

  • Change in Mini-Mental State Examination from baseline to end of treatment and to follow-up

    Measured at baseline, at 6 weeks (end of treatment), and at 3-months (follow-up)

  • Change in Barthel Index from baseline to end of treatment and to follow-up

    Measured at baseline, at 6 weeks (end of treatment), and at 3-months (follow-up)

  • Change in Fugl-Meyer Assessment from baseline to end of treatment and to follow-up

    Measured at baseline, at 6 weeks (end of treatment), and at 3-months (follow-up)

Study Arms (2)

Cognitive rehabilitation group

EXPERIMENTAL

Cognitive rehabilitation training with RGS in the clinic.

Behavioral: Cognitive rehabilitation training with RGS in the clinic

Passive control group

ACTIVE COMPARATOR

Passive/conventional cognitive training at home.

Behavioral: Passive/conventional cognitive training at home.

Interventions

Daily cognitive training with the Rehabilitation Gaming System (RGS) in the clinic during 6 weeks (5 days per week a 30 minutes).

Cognitive rehabilitation group

Daily conventional cognitive rehabilitation at home as recommended by the neurologist during 6 weeks (5 days per week a 30 minutes).

Passive control group

Eligibility Criteria

Age45 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Score on Mini-Mental State Examination between 18 - 24
  • Score on Montreal Cognitive Assessment less than 26
  • More than 2 points in upper limb motor scale MRC
  • Sufficient cognitive ability to understand and follow the experimental instructions

You may not qualify if:

  • Score on Mini-Mental State Examination below 18 or above 24
  • Score on Montreal Cognitive Assessment of 26 or above
  • Below 2 point in upper limb motor scale MRC
  • Hemianopia
  • Cognitive capacity that prohibits the execution of the experiment
  • Severe impairment like spasticity, aphasia or apraxia, major pain or other neuromuscular impairments or dependent on use of orthopedic devices that would interfere with the correct execution of understanding of the experiment
  • History of serious mental-health problems in acute or subacute phase
  • Patients that do not give their consent to participate in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (5)

  • Cicerone KD, Langenbahn DM, Braden C, Malec JF, Kalmar K, Fraas M, Felicetti T, Laatsch L, Harley JP, Bergquist T, Azulay J, Cantor J, Ashman T. Evidence-based cognitive rehabilitation: updated review of the literature from 2003 through 2008. Arch Phys Med Rehabil. 2011 Apr;92(4):519-30. doi: 10.1016/j.apmr.2010.11.015.

    PMID: 21440699BACKGROUND
  • Ball K, Berch DB, Helmers KF, Jobe JB, Leveck MD, Marsiske M, Morris JN, Rebok GW, Smith DM, Tennstedt SL, Unverzagt FW, Willis SL; Advanced Cognitive Training for Independent and Vital Elderly Study Group. Effects of cognitive training interventions with older adults: a randomized controlled trial. JAMA. 2002 Nov 13;288(18):2271-81. doi: 10.1001/jama.288.18.2271.

    PMID: 12425704BACKGROUND
  • Corbetta M, Ramsey L, Callejas A, Baldassarre A, Hacker CD, Siegel JS, Astafiev SV, Rengachary J, Zinn K, Lang CE, Connor LT, Fucetola R, Strube M, Carter AR, Shulman GL. Common behavioral clusters and subcortical anatomy in stroke. Neuron. 2015 Mar 4;85(5):927-41. doi: 10.1016/j.neuron.2015.02.027.

    PMID: 25741721BACKGROUND
  • Nair RD, Lincoln NB. Cognitive rehabilitation for memory deficits following stroke. Cochrane Database Syst Rev. 2007 Jul 18;(3):CD002293. doi: 10.1002/14651858.CD002293.pub2.

    PMID: 17636703BACKGROUND
  • Maier M, Ballester BR, Leiva Banuelos N, Duarte Oller E, Verschure PFMJ. Adaptive conjunctive cognitive training (ACCT) in virtual reality for chronic stroke patients: a randomized controlled pilot trial. J Neuroeng Rehabil. 2020 Mar 6;17(1):42. doi: 10.1186/s12984-020-0652-3.

MeSH Terms

Conditions

Cognition Disorders

Interventions

PITX2 protein, human

Condition Hierarchy (Ancestors)

Neurocognitive DisordersMental Disorders

Study Officials

  • Esther Duarte Oller, MD, PhD

    Parc de Salut Mar - Hospital de l'esperança

    PRINCIPAL INVESTIGATOR
  • Paul F.M.J. Verschure, PhD

    Director Specs

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD

Study Record Dates

First Submitted

June 21, 2016

First Posted

June 28, 2016

Study Start

July 1, 2016

Primary Completion

February 1, 2018

Study Completion

February 1, 2018

Last Updated

May 23, 2018

Record last verified: 2018-05